MARKET OVERVIEW

The India Surrogacy Market reached a size of USD 613.50 Million in 2024 and is expected to grow to USD 4,051.87 Million by 2033. The market is projected to expand at a CAGR of 21.47% between 2025 and 2033. This growth is driven by rising infertility rates, advances in assisted reproductive technologies, increasing awareness, and favorable regulations, alongside the growth of medical tourism and improved healthcare infrastructure. The report presents a thorough review featuring the India surrogacy market size, share, trends, and research of the industry.

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

INDIA SURROGACY MARKET KEY TAKEAWAYS

• Current Market Size: USD 613.50 Million in 2024
• CAGR: 21.47% during 2025-2033
• Forecast Period: 2025-2033
• Legal framework changes impact surrogacy demand; altruistic surrogacy permitted under the Surrogacy (Regulation) Act, 2021.
• Market influenced by increased infertility, lifestyle disorders, and delayed pregnancies in urban areas.
• Advancements in IVF and embryo transfer techniques improve success rates and patient outcomes.
• India remains a hub for surrogacy-related medical tourism with domestic and international patients.
• Fertility preservation services like egg and sperm freezing contribute to market growth.

Sample Request Link: https://www.imarcgroup.com/india-surrogacy-market/requestsample

MARKET TRENDS

The India surrogacy market growth is influenced considerably by regulatory changes and the rising demand for assisted reproductive technologies. The Surrogacy (Regulation) Act, 2021 permits only altruistic surrogacy, affecting market dynamics while many parents seek solutions within regulated clinics. Amendments in 2024 allow intending couples to use at least one gamete from themselves even if medically certified to need donor gametes. Single women must use self-eggs with donor sperm, reflecting evolving legal frameworks and impacting market demand.

Additionally, infertility prevalence, lifestyle disorders, and delayed pregnancies among urban couples drive market growth. IVF and embryo transfer advancements have enhanced success rates, boosting confidence in surrogacy. Despite restrictions, India remains a pivotal destination for surrogacy-related medical tourism, drawing domestic and international patients seeking fertility treatments under legal conditions.

Technological innovations are transforming the surrogacy landscape with techniques like preimplantation genetic testing (PGT), AI-assisted embryo selection, and embryo freezing. Clinics personalize treatments using data analytics, improving outcomes. The affordability of treatments compared to Western countries sustains India’s position as a preferred destination. The expansion of facilities such as Alka IVF Shree Kanak Hospital under Dr. Alka indicates growing infrastructure to meet increasing demand.

MARKET GROWTH FACTORS

Increasing infertility rates driven by lifestyle changes, delayed parenthood, and medical conditions are primary market growth factors. Advancements in assisted reproductive technologies such as IVF with intracytoplasmic sperm injection (ICSI) and preimplantation genetic screening enhance success rates, fueling confidence in surrogacy. Supportive altruistic surrogacy regulations provide a legal framework encouraging market expansion.

Rising awareness about surrogacy combined with improved healthcare infrastructure in India supports growth. Growing acceptance of non-traditional families and increasing demand from both domestic and international intended parents, including medical tourists, further drive market growth. The affordability of services relative to Western countries also contributes substantially.

The rise of fertility preservation services such as egg and sperm freezing allows intended parents to plan surrogacy with flexibility, enhancing market appeal. Personalized treatment approaches, use of advanced genetic testing, and data analytics optimize outcomes, translating to increased patient trust and market efficiency. Expansion of fertility clinics across multiple regions strengthens capacity to serve a broader demographic.

MARKET SEGMENTATION

Type Insights:

• Gestational Surrogacy: Surrogacy involving implantation of embryos not genetically related to the surrogate mother.
• Traditional Surrogacy: Surrogacy where the surrogate mother is genetically related to the child.

Technology Insights:

• IVF With ICSI: In-vitro fertilization procedures that include intracytoplasmic sperm injection technique.
• IVF Without ICSI: Standard in-vitro fertilization procedures without the use of ICSI.
• Intrauterine Insemination: A fertility treatment involving the direct placement of sperm into a woman's uterus.

Service Provider Insights:

• Hospitals: Medical institutions providing surrogacy and assisted reproductive services.
• Fertility Clinics: Specialized clinics focusing on fertility treatments including surrogacy.
• Others: Other service providers not classified as hospitals or fertility clinics.

REGIONAL INSIGHTS

The report covers major regional markets including North India, South India, East India, and West India. Specific dominant regions or market share data for these regions are Not provided in source.

RECENT DEVELOPMENTS & NEWS

On January 7, 2025, the Supreme Court of India agreed to review age restrictions in the country’s surrogacy legislation, scheduling a hearing for February 11. Current laws mandate intended fathers be aged 26-55 and mothers 23-50, with surrogate mothers required to be married, aged 25-35, have at least one biological child, and permitted to serve only once. The Court stressed the need for a database to prevent surrogate exploitation and multiple uses of the same surrogate.

Additionally, on December 23, 2024, Alka IVF Shree Kanak Hospital announced expansion plans under Dr. Alka, introducing new facilities in Jodhpur, Kota, Jhansi, and Udaipur, reflecting market growth and enhanced patient care offerings.

KEY PLAYERS

• Alka IVF Shree Kanak Hospital

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Get Your Customized Market Report: https://www.imarcgroup.com/request?type=report&id=30714&flag=E

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: [email protected],

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302